跳至主要内容
临床试验/CTRI/2024/07/070838
CTRI/2024/07/070838尚未招募4 期

A Comparative study to evaluate the efficacy and safety of Bempedoic acid versus Ezetimibe in patients with Dyslipidemia - NI

Afzal Noor0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Stable atherosclerotic cardiovascular disease
  • Uncontrolled LDL cholesterol level (fasting more than 70 mg/dl) on maximally tolerated dose of statin.(Atrovastatin 80 mg OD, Rosuvastatin 40 mg OD)

排除标准

  • Age less than 18 yr
  • BMI more or equal 40 kg/m sq.
  • Triglyceride levels more or equal to 500 mg/dl
  • History of statin intolerance
  • History of cardiac event in last 12 weeks
  • Pregnant and Lactating women.

研究者

发起方
Afzal Noor

相似试验

A study to compare the effectiveness and safety of... | 临床试验